Group B streptococcus (GBS) is the leading etiologic agent of bacterial meningitis and sepsis during the neonatal period, but it is an infrequent cause of meningitis in adults. We report 12 episodes of group B streptococcal meningitis in adults and review 52 cases reported in the literature. A total of 24 men and 40 women were included in the study; the mean age ({ SD) was 49.2 { 20.5 years (range, 17 -89 years). All the patients had cerebrospinal fluid cultures positive for GBS. Eighty-six percent of the patients had comorbid conditions, 50% had a distant focus of infection, and blood cultures yielded GBS for 78.7%. The overall case-fatality rate was 34.4% (22 patients). Factors associated with a poor outcome were advanced mean age ({ SD) (61.5 { 17.4 years vs. 42.8 { 19.2 years; P Å .0003) and the presence of complications on admission (P Å .0001). Seven percent of survivors had neurological sequelae. Group B streptococcal meningitis in adults has become increasingly frequent in recent years; it tends to occur in patients with severe underlying conditions and is associated with a high casefatality rate. Factors associated with a poor prognosis are advanced age and the occurrence of neurological and extraneurological complications.
Streptococcus agalactiae, or group B streptococcus
Patients and Methods (GBS), has emerged in recent decades as the leading cause Study population. We reviewed the hospital records of of bacterial meningitis and sepsis in neonates [1, 2] . Moreadults with GBSM diagnosed at the Hospital de la Santa Creu over, in recent years this organism has been recognized i Sant Pau in Barcelona, a teaching hospital with 950 beds, or with increasing frequency as a substantial cause of morbidat the Hospital Mutua de Terrassa in Terrassa, a teaching hospiity and mortality among adults [3, 4] . In recent reports, the tal with 608 beds; all episodes occurred between January 1982 annual incidence of group B streptococcal disease among and December 1996. These hospitals serve as general hospitals men and nonpregnant women has ranged from 2.4 cases for 670,000 inhabitants of Barcelona and 250,000 inhabitants per 100,000 population to 4.4 cases per 100,000 population of Terrassa. [3, 4] . The spectrum of group B streptococcal disease in Clinical criteria and definitions. The diagnosis of GBSM adults includes bacteremia with or without sepsis, cellulitis was made on the basis of clinical examinations, CSF data and other soft-tissue infections, pneumonia, arthritis, endoconsistent with purulent meningitis, and CSF cultures positive carditis, urinary tract infection, meningitis, osteomyelitis, for GBS. and pyomyositis [4 -10] .
A primary distant focus of infection was considered when Purulent meningitis is one of the most infrequently reported a patient had clinical symptoms and signs consistent with a focal infections caused by GBS in adults. In recent studies, focal infection distant from the CNS and GBS was isolated group B streptococcal meningitis (GBSM) accounted for 4% from the primary focus or from a blood culture. Communicaof all group B streptococcal infections [3, 11] . To date, two tions of the subarachnoid space with skin, sinuses, or mucosal reviews of the English-language literature concerning GBSM surfaces were not considered distant foci of infection. in adults have been published [8, 12] , but, to our knowledge, The findings of coma, seizures, or focal neurological signs, a comprehensive review of the worldwide literature has not detected on admission or subsequently, were considered neurobeen published. During a period of 15 years, physicians at our logical complications of GBSM. The development of shock, hospitals diagnosed 12 cases of GBSM, which we report herein.
acute respiratory failure, acute renal failure, or consumption We also review the previously reported cases of GBSM.
coagulopathy were considered extraneurological complications if they were related to group B streptococcal disease and were apparent on admission or shortly afterwards.
and had a clinical course that suggested persistent infection or extraneurological complications, one (8.3%) developed neurologic complications, and eight (66.7%) developed both extraif death occurred during the acute phase of infection. Otherwise, the patient was considered to be cured. neurological and neurological complications. Complications, in decreasing frequencies, were coma (seven patients), conReview of the literature. We searched for contemporary cases of GBSM through December 1996 with use of MEDsumption coagulopathy (seven), septic shock (six), acute renal failure (six), seizures (four), acute respiratory failure (four), LINE. The search strategy crossed the terms ''Streptococcus agalactiae'' or ''Streptococcus Group B'' and ''meningitis'' focal neurological signs (three), rhabdomyolisis (two), inappropriate secretion of antidiuretic hormone (one), and hypothermia or ''meningoencephalitis'' or ''meningit'' or ''meningita'' or ''meningite'' or ''meningites'' or ''meningitides'' or ''enceph-(one). Empirical antibiotic therapy was adequate for 11 patients, and one did not receive antibiotics. Eight patients alitis'' and ''adult'' or ''adulta'' or ''adulte'' or ''adulten'' or ''adultes'' or ''adulthood'' or ''adulto'' or ''adultos'' or (66.7%) died. Survivors recovered without sequelae. Literature review. We found 72 cases of GBSM in the ''adults.'' The references from the retrieved citations were culled for additional reports, especially earlier reports not enliterature [5, 8 -10, 12, 16 -56] ; the first one [16] was reported in 1942, and the last was reported in 1996 [56] . The clinical tered in MEDLINE. Cases of GBSM were included provided the diagnosis had been proved by isolation of GBS from a characteristics of patients with GBSM are shown in table 1. General reviews of acute bacterial meningitis and of bacteremic CSF culture, the patient was aged §15 years, and the reports contained in-depth histories with information on age, sex, cogroup B streptococcal disease also included isolated cases of GBSM, but those reported in large series [3, 11, 57 - [14] . A P value of õ.05 was considered to indicate statistical significance.
age ({ SD) of the patients was 49.2 { 20.5 years, ranging from 17 to 89 years. Sixteen patients (25%) were older than 65 years. The distribution of patients by age groups and the case-fatality Results rate is shown in figure 1 . Fifty-five patients (85.9%) had comorbid conditions, which are listed in table 2. GBSM occurred spontaneStudy population. During the 15-year study period, GBS was isolated in pure growth from CSF cultures for 12 of 278 ously in 60 patients (93.7%), and in half of these patients, a distant focus of infection was found. Four patients (6.2%), two of whom patients ú15 years of age who had acute bacterial meningitis. Acute bacterial meningitis was diagnosed on the basis of conhad endocarditis, presented with petechiae. The CSF biochemical and cytological profiles were fully consistent with purulent meninsistent clinical data, suggestive cytological and biochemical findings such as an elevated CSF protein level, a decreased gitis (table 3) . Gram-stained smears of the CSF disclosed grampositive cocci for 36 (83.7%) of 43 patients; blood cultures were CSF/blood glucose ratio and polymorphonuclear pleocytosis, and a CSF culture positive for pathogenic bacteria [15] . If a positive for 48 (78.7%) of 61 patients, and other cultures were positive for 23 (35.9%) of 64 patients. Thirty-eight patients CSF culture was negative but pleocytosis ( §100 neutrophils/ mm 3 ) was present, culture-negative bacterial meningitis was (59.4%) had uneventful in-hospital courses, whereas seven patients (10.9%) had neurological complications, six (9.4%) had diagnosed [15] . Therefore, the prevalence of GBSM among adult patients in our study was 4.3%. There were five men and extraneurological complications, and 13 (20.3%) developed both types of complications. seven women, and the mean age ({ SD) was 51.7 { 21.7 years (range, 18 -78 years).
Antibiotic therapy was specified for 59 patients, 40 (70.2%) of whom received penicillin either alone or in combination The clinical characteristics of all the patients, including ours, are summarized in table 1. All of our patients had one or more with other antimicrobial agents; two patients did not receive antibiotic therapy. Empirical therapy was adequate for all comorbid conditions. Gram-stained smears of the CSF showed gram-positive cocci for nine patients (75%), and blood cultures treated patients. The overall case-fatality rate was 34.4% (22 patients). Three (7.1%) of 42 survivors had neurological seyielded GBS for 11 patients (91.7%). Only one patient (8.3%) did not develop complications, whereas two (16.7%) developed quelae (deafness in all three cases). NOTE. Amox Å amoxicillin; Amp Å ampicillin; Cefur Å cefuroxime; CHD Å coronary heart disease; Chl Å chloramphenicol; Clv Å clavulanate; Cm Å clindamycin; Ctax Å cefotaxime; Ctri Å ceftriaxone; Czid Å ceftazidime; Czox Å ceftizoxime; DM Å diabetes mellitus; ESRD Å end-stage renal disease; Gm Å gentamicin; IVDA Å intravenous drug abuse; Mtz Å metronidazole; NA Å data not available; Net Å netilmicin; NR Å not reported; Pen Å penicillin; PVD Å peripheral vascular disease; SLE Å systemic lupus erythematosus; UTI Å urinary tract infection; Vm Å vancomycin.
Results of univariate analysis of clinical parameters, with complications (P Å .0001). For patients with comorbid condirespect to mortality, are shown in table 3. The case-fatality rate tions, the respective case-fatality rates were 9.4%, 50.0%, paralleled the number of complications and was 7.9% for those 83.3%, and 90.9% for patients with no complications, neurowho had no complications, 42.9% for those who had neurologilogical complications, extraneurological complications, or both cal complications, 83.3% for those who had extraneurological types of complications (P Å .0001), whereas for patients with complications, and 84.6% for those who had both types of no comorbid conditions (nine patients), these rates were 0 for the six patients with no complications, 0 for the one with neurological complications, and 50% for the two with extraneurological complications (P Å .13). The case-fatality rate for patients treated with penicillin was 20%, and that for patients treated with other antibiotics was 58.8% (P Å .01). However, a higher proportion of comorbidity (100% vs. 76.9%; P Å .07) and complications on admission (70.6% vs. 30%, P Å .01) was observed for patients not treated with penicillin than for those treated with penicillin. There were no statistically significant differences with respect to the presence of distant foci of infection, the CSF/blood glucose ratio, the CSF cell counts, positivity of the CSF gram-stained smear, and presence of bacteremia between patients with GBSM who survived and those who died (table 3) .
Comparison of our patients with those described in the litera- meningitis represents Ç3% of the total number of cases, deAutoimmune disease and/or pending on the population studied and when the study was immunosuppressive conditions* 11 (17.2) done [1] . Among series dealing with adult patients exclusively, Postpartum or pregnancy 9 (14.1) the percentage of streptococcal meningitis ranged from 3.1%
Hepatic cirrhosis and/or alcohol abuse 8 (12.5) to 5.8% [15, 58, 63, 64] . Among our adult patients, the preva-CSS 7 (10.9) Debilitating diseases † 7 (10. 9) lence of nonpneumococcal streptococcal meningitis was 6.1%, pathogens such as Listeria monocytogenes and gram-negative † Includes chronic renal failure (4), congenital hydrocephalus (1), and multiple sclerosis (2) .
bacilli [64, 65] . ‡ Includes colon (1), renal (1), hepatic (1), nasopharyngeal (1), and cervical Two groups of adults are at higher risk for group B strepto- / 9c3f$$no40 10-17-97 22:02:44 cida UC: CID 12 patients. This finding is due to the high incidence of this sterilization is directly related to the occurrence of neurological sequelae [73] . It is surprising that in our review, patients treated condition in Spain, and it is known that cirrhosis is a risk factor for infections caused by encapsulated bacteria [57] . Excluding with penicillin did significantly better than patients treated with other antibiotics. However, this finding is misleading because puerperal women, the male to female ratio among patients with GBSM was 0.92:1. This figure is similar to such ratios reported more-severely ill patients were treated with other antibiotics, whereas those not so ill were treated only with penicillin. When for acute bacterial meningitis in general [58, 66 -68] but lower than those reported in other studies concerning group B streptowe adjusted for the severity of patients' conditions according to the presence of comorbidity and neurological and extraneucoccal disease, where the ratios ranged between 1.66:1 and 2:1 [3, 4, 61] . Most cases of GBSM in adults have been community rological complications on admission, we did not find any differences between those treated with penicillin alone and those acquired, consistent with the low rates of nosocomial bacteremia due to GBS reported in nationwide studies [69] . However, treated with other antimicrobials. In summary, GBS is an infrequent, although important, etioin reviews of group B streptococcal bacteremia, a significant proportion of cases are hospital acquired [4, 5, 8] .
logic agent of bacterial meningitis in adults. Indeed, GBSM has been reported with increasing frequency in recent years. From a clinical point of view, acute bacterial meningitis caused by GBS is indistinguishable from meningitis caused by
Patients frequently have severe comorbid conditions and distant foci of infection. Bacteremia is a usual finding. The associated other pyogenic bacteria. However, some of the patients (6.2%) presented with petechiae. The appearance of petechiae has a case-fatality rate is exceedingly high, especially among the elderly and among patients who develop complications. Segood predictive value for the diagnosis of meningococcal meningitis in adults [70] , and given the epidemiology of bacterial quelae among survivors are infrequent. epidemiology in Spain, most of these patients have meningococcal meningitis [71] . Nevertheless, when GBSM patients
